EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between sirolimus trough concentration and clinical outcomes during maintenance therapy after kasabach-merritt phenomenon remission in kaposiform hemangioendothelioma: a pilot exploratory study

Wei Feng, Jinping Hou, Yun He, Xiaohong Die, Zhenhua Guo, Wei Liu, Yi Wang

Frontiers in Pharmacology · 18.11.2026 · 17

DOI: 10.3389/fphar.2026.2002911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.11.2026. Verfasst von Wei Feng und 6 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor that may be complicated by Kasabach-Merritt phenomenon (KMP), a life-threatening consumptive coagulopathy syndrome. Although sirolimus has improved clinical outcomes, the optimal trough concentration during maintenance therapy after KMP remission remains unclear. This study aimed to evaluate the efficacy and safety associated with varying sirolimus exposure during the 12-month maintenance phase.

Methods

We retrospectively reviewed 26 patients with KHE who achieved KMP remission and received sirolimus maintenance therapy for at least 12 months. Patients were classified according to their average maintenance-phase sirolimus trough concentration into low exposure group (4∼8 ng/mL, n = 14) and high exposure group (8∼15 ng/mL, n = 12). Lesion regression, KMP recurrence, and treatment-related adverse events (AEs) were compared between groups. Multivariate Firth-corrected Logistic regression was applied for exploratory analysis of factors associated with KMP recurrence. To avoid reverse causation, only trough concentrations obtained prior to KMP recurrence were included in the regression models; measurements collected after recurrence were excluded.

Results

Baseline characteristics were comparable between the two groups. Both groups achieved progressive lesion regression during maintenance therapy. The high exposure group showed a significantly higher regression rate at 3 months; however, no significant differences were observed at 6 or 12-months follow-ups. In this small cohort, no statistically detectable difference in the frequency of sirolimus-related AEs was observed across exposure groups. Numerically, KMP recurrence was less common in the high exposure group (p = 0.036). In the exploratory multivariate analysis adjusting for clinical confounders, higher sirolimus exposure prior recurrence showed a protective trend against KMP recurrence but was not statistically significant (OR = 0.071, 95% CI = 0.003∼1.601, p = 0.096).

Conclusion

This exploratory analysis demonstrated that varying sirolimus exposure achieves comparable efficacy and safety within the 12 months maintenance phase among patients with KHE after KMP remission. High sirolimus exposure may accelerate early lesion regression and potentially reduce recurrence risk, although an independent protective benefit remains unconfirmed. Individualized sirolimus maintenance strategies guided by disease trajectory and therapeutic drug monitoring may be preferable to routine targeting of high trough concentrations.

Zitieren

APA

Feng, W., Hou, J., He, Y., Die, X., Guo, Z., Liu, W., & Wang, Y. (2026). Association between sirolimus trough concentration and clinical outcomes during maintenance therapy after kasabach-merritt phenomenon remission in kaposiform hemangioendothelioma: a pilot exploratory study. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.2002911

Vancouver

Feng W, Hou J, He Y, Die X, Guo Z, Liu W, et al. Association between sirolimus trough concentration and clinical outcomes during maintenance therapy after kasabach-merritt phenomenon remission in kaposiform hemangioendothelioma: a pilot exploratory study. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.2002911

BibTeX
@article{Feng2026,
  author = {Feng, Wei and Hou, Jinping and He, Yun and Die, Xiaohong and Guo, Zhenhua and Liu, Wei and Wang, Yi},
  title = {Association between sirolimus trough concentration and clinical outcomes during maintenance therapy after kasabach-merritt phenomenon remission in kaposiform hemangioendothelioma: a pilot exploratory study},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.2002911}
}
Kostenlos starten →